Pavol Fuček graduated from the Faculty of General Medicine of Comenius University in Bratislava and has over 13 years’ experience in designing and conducting of clinical trials. He joined SOTIO in position of Head of Pharmacovigilance in 2014. Later that year he has also taken on the lead of the SOTIO Quality Assurance Department. In 2016 he was appointed to the role of CEO of Accord Research, a contract research organization fully owned by PPF, which manages the SOTIO clinical trials as well as provides services to other clients.
Prior to joining SOTIO, Pavol worked in contract research companies. His experience includes all stages of phase 1-4 clinical trials in different indication areas, with various compounds of large pharma companies as well as biotech start-ups. In Premier Research he acted as safety physician and medical monitor, and was in charge of leading the European drug safety teams. As Director of Pharmacovigilance in Accovion, he gained additional experience of post-marketing pharmacovigilance organization.
Before his involvement in pharma and biotech industry, Pavol worked in the field of organization development mainly within the Red Cross movement. He held different international positions focused on knowledge and change management, strategic planning and training design.